Aimovig

Aimovig (Erenumab) is a subcutaneous injection designed for migraine prevention. This medication targets specific pathways to help reduce the frequency of migraine attacks. Learn more about Aimovig's uses and benefits.

Aimovig is primarily used for the prevention of migraine headaches in adults. It works by targeting a protein involved in migraine attacks, potentially reducing their frequency and severity. People often ask, 'What is Aimovig used for?' and the answer is focused on its role in migraine prevention.

Common effects of Aimovig may include injection site reactions, such as redness or pain. Some users might experience constipation or muscle tightness. These effects vary and are not exhaustive; individual experiences may differ.

Aimovig should be used with caution in individuals with a history of hypersensitivity to Erenumab or any of its components. It is important to follow the advice of a healthcare provider regarding its use and to report any adverse reactions promptly.

Aimovig may interact with other medications, particularly those that affect the same biological pathways. It is advisable to consult a healthcare provider before combining Aimovig with other treatments. Alcohol and certain supplements might also influence its effectiveness.